| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Department M (Endocrinology and Diabetes) (H.N., J.O.L.J., N.M., J.S.C., A.F.), Aarhus Kommunehospital, and Medical Research Laboratories (J.F., N.M., H.O., A.F.), Institute of Experimental Clinical Research, Aarhus University, DK-8000 Aarhus, Denmark
Address all correspondence and requests for reprints to: Helene Nørrelund, M.D., Ph.D., Medical Department M, Aarhus Kommunehospital, DK-8000 Aarhus C, Denmark. E-mail: helenenorrelund{at}dadlnet.dk.
The present study investigates the possible stimulatory effect of endogenous GH on IGF and IGF-binding protein (IGFBP) levels during fasting. Eight normal subjects were examined on four occasions: 1) in the basal postabsorptive state; 2) after 40 h of fasting; 3) after 40 h of fasting with somatostatin suppression of GH; and 4) after 40 h of fasting with suppression of GH and exogenous GH replacement. The two somatostatin experiments were identical in terms of hormone replacement (except for GH). Short-term fasting led to a 50% reduction in free IGF-I. The reduction in free IGF-I was paralleled by an increase in IGFBP-1, an increase in the complex formation of IGFBP-1 and IGF-I, and a modest reduction in IGFBP-3 proteolysis. GH deprivation during fasting led to a 35% reduction in total IGF-I and a 70% reduction in free IGF-I. GH replacement increased free and total IGF-I to levels similar to those observed during plain fasting and decreased IGFBP-1, however, without affecting IGFBP-1-bound IGF-I. Finally, IGFBP-3 proteolysis was slightly increased by GH replacement. In conclusion, the major new finding of the present study is that the GH hypersecretion seen during short-term fasting is not merely secondary to a reduction in IGF bioactivity.
This work was supported by the Danish Research Council Grant 9600822 (Aarhus UniversityNovo Nordisk Centre for Research in Growth and Regeneration) and Grants 9700592 and 22020141; the Eva and Henry Frænkels Memorial Foundation; and the Hørslev Foundation.
Abbreviations: IGFBP, IGF-specific binding protein; IRMA, immunoradiometric assay; rh, recombinant human; tIGF, total IGF; WIB, Western immunoblotting; WLB, Western ligand blotting.
This article has been cited by other articles:
![]() |
L. Moller, L. Dalman, H. Norrelund, N. Billestrup, J. Frystyk, N. Moller, and J. O. L. Jorgensen Impact of Fasting on Growth Hormone Signaling and Action in Muscle and Fat J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 965 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Alemany, B. C. Nindl, M. D. Kellogg, W. J. Tharion, A. J. Young, and S. J. Montain Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity J Appl Physiol, July 1, 2008; 105(1): 58 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Stoving, J.-W. Chen, D. Glintborg, K. Brixen, A. Flyvbjerg, K. Horder, and J. Frystyk Bioactive Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-1 in Anorexia Nervosa J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2323 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abe, T. Matsunaga, K. Kameda, H. Tomita, T. Fujiwara, H. Ishizaka, H. Hanada, K. Fukui, I. Fukuda, T. Osanai, et al. Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1387 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight J. Nutr., July 1, 2005; 135(7): 1667 - 1672. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |